This page summarises research not otherwise described on our eczema, vitiligo, cellulitis and skin cancer pages. We are particularly interested in rare diseases. The evidence-base for such diseases is often poor as relatively few people are affected, making performing clinical trials difficult. However, we have found that by taking a broad collaborative approach, supported by the UK Dermatology Clinical Trials Network (UK DCTN), such difficulties can be overcome.
Information for all of our other research projects is detailed in the table below.
Recently completed trials
Bullous pemphigoid is a skin condition affecting mainly elderly people, which results in tense, itchy blisters and painful skin erosions that can affect the whole body.
The BLISTER study compared the safety and effectiveness of doxycycline with prednisolone for initial treatment of bullous pemphigoid.
Erosive lichen planus is a chronic, inflammatory, scarring skin condition that can effect the vulval area.
The hELP trial evaluated the effectiveness of four different tablet treatments (hydroxychloroquine, methotrexate, mycophenolate mofetil, prednisolone) for moderate-to-severe vulval erosive lichen planus.
Pyoderma gangrenosum is a rare skin condition, and thought to be a disorder of the immune system. It causes painful, rapidly spreading ulcers on the skin, and can take many months to heal.
The STOP GAP trial compared how effective oral prednisolone was compared to oral ciclosporin for the treatment of pyoderma gangrenosum.